AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
184.60
-0.98 (-0.53%)
At close: May 9, 2025, 4:00 PM
184.97
+0.37 (0.20%)
After-hours: May 9, 2025, 7:59 PM EDT
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,043,036
Profits / Employee
$75,545
Market Cap
326.55B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABBV News
- 3 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit – ABBV - GlobeNewsWire
- 4 days ago - AbbVie to Present at the Bank of America Securities Healthcare Conference - PRNewsWire
- 5 days ago - Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms - CNBC
- 9 days ago - BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project" - PRNewsWire
- 10 days ago - Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom - CNBC
- 11 days ago - Best Dividend Aristocrats For May 2025 - Seeking Alpha
- 11 days ago - Stock Of The Day: AbbVie's Rally Looks Stretched — Could A Reversal Be Next? - Benzinga
- 11 days ago - RINVOQ® (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA) - PRNewsWire